Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2010
10/28/2010US20100273202 Codon-optimized nucleic acid for coding apo-clytin-ii and method for using the same
10/28/2010US20100273201 Acetolactate Synthase (ALS) Selectable Marker from Trichoderma reesei
10/28/2010US20100273200 In-Vitro Model of Blood-Brain Barrier, In-Vitro Model of Diseased Blood-Brain Barrier, and Drug Screening Method, Analysis Method for Functions of Diseased Blood-Brain Barrier, and Analysis Method for Pathogenesis Using the Same
10/28/2010US20100273194 Immunoreactive ehrlichia p120/p140 epitopes and uses thereof
10/28/2010US20100273180 Decorin polypeptide and methods and compositions of use thereof
10/28/2010US20100273160 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
10/28/2010US20100273154 Novel glycosyltransferases and polynucleotides encoding the same
10/28/2010US20100272876 Wheat variety msu line e0028
10/28/2010US20100272826 Nano/macroporous bone tissue scaffolds for regenerative medicine
10/28/2010US20100272780 CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOF
10/28/2010US20100272760 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
10/28/2010US20100272750 Hpv polyepitope constructs and uses thereof
10/28/2010US20100272742 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
10/28/2010US20100272738 Anti-ox40l antibodies and methods using same
10/28/2010US20100272737 Novel Peptides and Protein and Uses Thereof
10/28/2010US20100272734 Compositions and methods for increasing muscle growth
10/28/2010US20100272731 Engineered anti-il-23p19 antibodies
10/28/2010US20100272730 Antigenic GM-CSF Peptides And Antibodies To GM-CSF
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272724 Binding molecules capable of neutralizing rabies virus and uses thereof
10/28/2010US20100272720 Antibody Fusion Proteins with a Modified FcRn Binding Site
10/28/2010US20100272719 Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272714 Anti-ADDL Antibodies and Uses Thereof
10/28/2010US20100272709 Cathepsin l mediated diseases and associated methods and products
10/28/2010US20100272700 Dendritic cell precursors
10/28/2010US20100272696 Human Bone-Forming Cells In The Treatment of Inflammatory Rheumatic Diseases
10/28/2010US20100272695 Cell compositions derived from dedifferentiated reprogrammed cells
10/28/2010US20100272694 Clinic compliant method for banking human placental mesenchymal cells
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010US20100272640 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
10/28/2010CA2795268A1 Methods for obtaining fetal genetic material
10/28/2010CA2759608A1 Methods for mitochondrial dna replacement in oocytes
10/28/2010CA2759258A1 Method for production of chrysanthemum plant having delphinidin-containing petals
10/28/2010CA2759244A1 Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
10/28/2010CA2759146A1 Antibody containing igg2 having amino acid mutation introduced therein
10/28/2010CA2759069A1 Perilla-derived promoter functioning in petals
10/28/2010CA2757764A1 Cancer antigen helper peptide
10/28/2010CA2757079A1 Control of protein glycosylation and compositions and methods relating thereto
10/27/2010EP2243837A1 Carotene synthase gene and uses therefor
10/27/2010EP2243835A2 Antibodies against insulin-like growth factor I receptor and uses thereof
10/27/2010EP2243827A1 Serum-free mammalian cell culture medium, and uses thereof
10/27/2010EP2243826A2 Mesenchymal stem cells and uses therefor
10/27/2010EP2243825A1 Method for the generation of a skin model and skin model
10/27/2010EP2243789A1 P.gingivalis antigenic composition
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2242847A2 Transgenic non-human mammal for the constant region of the g-class human immunoglobulin heavy chain and applications thereof
10/27/2010EP2242839A2 Methods of obtaining antigen-specific t cell populations
10/27/2010EP2242838A1 Stem-like cells and method for reprogramming adult mammalian somatic cells
10/27/2010EP2242837A1 Cell culture matrices
10/27/2010EP2242506A2 Method of treating erythropoietin hyporesponsive anemias
10/27/2010EP2242449A1 Method for manufacturing a tissue-engineered construct
10/27/2010EP1649011B1 Culture method for keratinocytes and use thereof
10/27/2010EP1567155B1 Administration of dendritic cells partially matured in vitro for the treatment of tumors
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1878861B Method of isolating and culturing mesenchymal stem cell derived from cryopreserved umbilical cord blood
10/27/2010CN1633501B Transgenic plants expressing CIVPS or intein modified proteins and related method
10/27/2010CN1617742B Methods for treating cancer by using tumor-derived dentrical cell inhibitory factor antagonist in combination with toll-like receptor agonist
10/27/2010CN1384877B Rescue of mumps virus from cDNA
10/27/2010CN101874109A Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same
10/27/2010CN101874108A Compositions for treating an intestinal inflammatory condition
10/27/2010CN101874107A Uses of a glycoprotein VI (GPVI) inhibitor
10/27/2010CN101874042A Method of modifying isoelectric point of antibody via amino acid substitution in cdr
10/27/2010CN101870983A Wintersweet gene containing thioesterase functional domain and application in drought-tolerant gene engineering thereof
10/27/2010CN101870981A Expression and purification method of heme oxygenase-1, and epitopes thereof
10/27/2010CN101870977A Method for cultivating anti-cyanosis transgenic cotton and special expression vector thereof
10/27/2010CN101870972A Salt induced promoter and application thereof
10/27/2010CN101870962A Method for constructing Tibetan antelope skin fibroblast line
10/27/2010CN101870889A Method for cellular tissue multiplication from jatropha curcas
10/27/2010CN101870735A Novel high-glycosylation erythropoietin immune fusion protein
10/27/2010CN101870734A Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
10/27/2010CN101870730A Anti-CD-20 monoclonal antibody
10/27/2010CN101870729A Coagulation factor vii polypeptides
10/27/2010CN101870727A Protein related to rice grain shape and height and coding gene and application thereof
10/27/2010CN101869715A Cell particles carrying interfering ribonucleic acid (RNA), preparation method and application thereof
10/27/2010CN101869707A Methods for enhancing innate and adaptive immunity and antigen immunogenicity
10/27/2010CN101434937B Paulownia 4-coumaric acid: coenzyme A ligase gene and use thereof
10/27/2010CN101319199B Method for cell abduction generation of taxone with Chinese yew
10/26/2010USRE41888 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
10/26/2010USRE41887 increases or maintains the number of functional cells of a predetermined type in a mammal by killing or inactivating autoimmune cells and re-educating the host immune system; Type 1 diabetes mellitus
10/26/2010US7820894 Maize variety PHH8E
10/26/2010US7820893 Maize variety PHGMA
10/26/2010US7820892 Maize variety PHF0D
10/26/2010US7820891 Maize variety PHV6K
10/26/2010US7820879 generating petunia transformants overexpressing the ZPT2-3 gene under the control of the CamV 35S promoter ; no adverse effects on plant growth
10/26/2010US7820877 Human heavy chain variable regions, human kappa light chain variable regions and encodes only mu isotype; human kappa light chain variable regions and encodes mu and gamma-2 isotypes; double-inactivated mouse Ig locus
10/26/2010US7820876 Animal model for evaluating neurodegenerative disorders and identifying neuroprotective agents
10/26/2010US7820807 can bind to and stimulate professional and non-professional human antigen-presenting cells, enhance the stimulatory effect of CD40L on CD40 positive cells and/or induce phenotypical maturation of monocyte derived dendritic cells
10/26/2010US7820798 Tumor necrosis factor-gamma
10/26/2010US7820797 Glycolipopeptide antibodies
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820621 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis
10/26/2010US7820453 Reacting astemizole with potassium channel moderators; complexing; calibration; kits
10/26/2010US7820447 drug screening; for carcinomas, especially lymphoma carcinomas
10/26/2010US7820441 Production of viral vectors
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820439 Using murine pluripotent stem cells to generate culture of gamma aminobutyric acid (GABA) expressing neurons for use in treatment and prevention of neurodegenerative disorders; cell replacement therapies; regenerative medicines
10/26/2010US7820438 Primary cultured adipocytes for gene therapy
10/26/2010US7820437 a cell having double mutations of the hERG gene that lead to charge reversal amino acid substitutions at residues 466 and 534 of the wild type Kv11.1 channel protein; Drug-induced acquired long QT syndrome; cardiovascular disorders
1 ... 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 ... 1827